Skip to content

Clinical trials

Completed Heartburn trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heartburn Status: Completed Country / region: United States Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20044
20054
20067
20072
20086
20097
20102
20112
20121
20132
20143
20152
20163
20193
20201
20211
20223
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
AstraZeneca6
Novartis6
Mayo Clinic3
Phathom Pharmaceuticals, Inc.3
University of North Carolina, Chapel Hill3
Eisai Inc.2
Microbiome Health Sciences2
Vecta Ltd.2
Addex Pharma S.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heartburn57
Gastroesophageal Reflux34
Esophagitis5
Dyspepsia4
Abdominal Pain3
Laryngopharyngeal Reflux3
Diarrhea2
Inflammation2
Parasomnias2
Anxiety Disorders1

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.